Covid Report: Why Moderna's Vaccine Prodded A Mass Biotech Sell-Off

Covid Report: Why Moderna's Vaccine Prodded A Mass Biotech Sell-Off

Moderna prodded a sell-off Wednesday among biotechs as investors digested a volunteer's account of systemic side effects tied to the company's experimental coronavirus vaccine.